Steward Partners Investment Advisory’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

Steward Partners Investment Advisory’s Portfolio PARN Stock Details PARN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,000	Closed	–	–	3555
2021 Q2	$0	Buy	+1,000	New	–	﹤0.01%	7623

Steward Partners Investment Advisory's PARN Position: Q3 2021 in Review

Steward Partners Investment Advisory sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q3 2021, closing a stake of 1,000 shares.

Steward Partners Investment Advisory first reported a position in PARN in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 0 funds tracked by Wall St. Rank hold PARN as of Q3 2021.

Steward Partners Investment Advisory reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q3 2021 after selling out during the quarter.
Steward Partners Investment Advisory sold 1,000 Parnell Pharmaceuticals Holdings Ltd shares in Q3 2021.
Steward Partners Investment Advisory first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q2 2021 and held it in 1 quarter.
Steward Partners Investment Advisory's Parnell Pharmaceuticals Holdings Ltd position peaked at $0 in Q2 2021.
0 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q3 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2021, filed 12 Nov 2021.